ZUVAMOR

This brand name is authorized in South Africa

Active ingredients

The drug ZUVAMOR contains one active pharmaceutical ingredient (API):

1 Rosuvastatin UNII 83MVU38M7Q - ROSUVASTATIN CALCIUM

Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles. Read about Rosuvastatin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZUVAMOR Film-coated tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AA07	Rosuvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ZA	Health Products Regulatory Authority	Identifier(s): 36/7.5/0353, 36/7.5/0354, 36/7.5/0355, 43/7.5/1138